MENU

To Stop or Not To Stop: MS Disease Modifying Therapy

John Corboy, MD, Michelle Dougherty, MD, Robert T. Naismith, MD

John Corboy, MD and Robert Naismith, MD probe the question of when to stop disease-modifying therapies in MS. They assess various factors to consider when discontinuing therapy and offer an update on new research to address the effects of therapy cessation.

More From This Series

Play Button
Politics Without Partisanship: Lobbying for Neurology

Janice Wiesman, MD, Michelle Dougherty, MD

Play Button
The Value of Patient-Reported Sleep Scales

Michelle Dougherty, MD, Rachel Marie Salas, MD

Play Button
Breaking Down New Research and Therapies in Multiple Sclerosis

Michelle Dougherty, MD, Peter Calabresi, MD

Play Button
To Stop or Not To Stop: MS Disease Modifying Therapy

John Corboy, MD, Michelle Dougherty, MD, Robert T. Naismith, MD

Show More